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Some children with diabetes, despite their exemption, insist on fasting in Ramadan. We evaluated the
safety of fasting among children with Type-1 diabetes.
Methods: During Ramadan 2007, 20 children with Type-I diabetes were recruited and divided into two
groups. Short term diabetes complications were recorded. Changes in weight, HbA1C and lipid proﬁle
before and after Ramadan were compared.
Results: Fasting group (n = 12, mean age 12.4 years). Non-fasting group (n = 8, mean age 10.5years)
showed no signiﬁcant difference in HbA1c (P = 0.9), weight (P = 0.96) or fasting lipid proﬁles.
Conclusion: Supervised fasting with close observation may be safe with no short-term parameter
changes.
 2010 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.1. Introduction
Adult Muslims are obliged to start fasting during the month of
Ramadan. Fasting entails refraining from all food, drink, tablets
and injections between sunrise and sunset; a period which varies
by geographical location and season. Children, elderly people, trav-
elers, pregnant or nursing women and unhealthy individuals are
exempt from fasting [1]. Although exempt, many diabetics, both
adults and children, refuse to take this concession as they feel psy-
chologically and spiritually inclined to fast along with other
Muslims.
Ramadan fasting may directly inﬂuence the control of diabetes
because of the month-long changes in meal times, types of foods,
use of medication and daily lifestyle [2]. During fasting eating and
drinking is exclusively nocturnal. A fasting person typically takes
two meals: a large, high caloric meal after sunset (Iftar) and a
small, low calorie meal just before sunrise (Sahor). Small snacks
may be taken between these two main meals. Meals are usually
high in carbohydrates and fat content [3]. Many may fast without
medical guidance, and may develop complications [4–7].
In spite of the observation that many children and adolescents
with diabetes do fast during Ramadan particularly in Muslim coun-
tries, little is known about the safety or metabolic effects of fasting
in children with diabetes.ellitus. Published by Elsevier Ltd.
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OThe aim of this study is to look into the safety and metabolic
consequences of Ramadan fasting among children with Type I dia-
betes mellitus (T 1DM).
2. Methods
This prospective case control study was conducted at the King
Abdulaziz Medical City, Riyadh, Saudi Arabia during Ramadan
1428 (September 13–October 12, 2007). Patients were recruited
3 months before the start of Ramadan, according to the following
criteria:
We included children aged between 8 and 14 years who had
Type 1 diabetes mellitus for more than one year, who agreed and
consented to participate in the study. Patients with no recurrent
hypoglycemia, or long term diabetes mellitus related complica-
tions, were excluded.
Outcome measures included number of hypoglycemic episodes
or DKA during fasting, Changes in HbA1C, and lipid proﬁle (choles-
terol, triglycerides, LDL and HDL) after fasting and weight and BMI
pre and post Ramadan.
2.1. Study protocol
Patients were divided into two groups, based on whether they
chose to fast. Those who elected not to fast during Ramadan were
considered as the ‘non-fasting group’, and were used as the control
group, whereas patients who had chosen to fast were considered as
the ‘fasting group’. Patients in the fasting group who experienced
hypoglycemia were instructed to break their fast. Patients who
withdrew from the study were not replaced. During non-fastingpen access under CC BY-NC-ND license.
Table 1
Comparing weight, HbA1c and lipid proﬁle before and at the end of Ramadan among
fasting and non-fasting groups.
Parameters Patient
groups
Before
Ramadan
End of
Ramadan
Difference
P value
Weight (kg) Fasting 42.2 (±9.6) 42.6 (±9.4) 0.152
Non fasting 36.6 (±7.4) 37.1 (±7.68) 0.345
Hb1Ac* (%) Fasting 10.4 (±2.17) 10.4 (±2.07) 1.000
Non fasting 10.6 (±1.4) 10.4 (±1.2) 0.483
Total cholesterol
(mmol/L)
Fasting 4.3 (±0.4) 4.4 (±0.3) 0.445
Non fasting 4.4 (±0.3) 4.5 (±0.5) 0.944
Triglyceride
(mmol/L)
Fasting 0.62 (±0.15) 0.62 (±0.17) 0.514
Non fasting 0.6 (±0.2) 0.6 (±0.2) 0.674
LDL (mmol/L) Fasting 2.6 (±0.3) 2.7 (±0.3) 0.333
Non fasting 2.6 (±0.3) 2.3 (±0.9) 0.499
HDL (mmol/L) Fasting 1.48 (±0.23) 1.42 (±0.13) 0.445
Non fasting 1.5 (±0.3) 1.6 (±0.3) 0.674
LDL: low density lipoprotein cholesterol; HDL: high density lipoprotein cholesterol.
* Normal non-diabetic range 4.2–6.4%.
Table 2
Comparing the change in weight, HbA1c and lipid proﬁle before and at the end of
Ramadan between fasting and non-fasting groups.
Parameters of
mean
Differences before
and at the end of
Ramadan non
fasting
Differences before
and at the end of
Ramadan fasting
Difference
P value
Weight (kg) 0.39 (±.96) 0.37 (±.76) 0.968
Hb1Ac (%) 0.14 (±1.0) 0.00 (±1.05) 0.904
Total cholesterol
(mmol/L)
0.49 (±0.48) 0.13 (±0.57) 0.573
Triglyceride
(mmol/L)
0.04 (±0.17) 0.03 (±0.14) 0.829
LDL (mmol/L) 0.23 (0.85) 0.16 (0.48) 0.408
HDL (mmol/L) 0.02 (±0.28) 0.07 (±0.19) 0.360
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on physician’s advice. All patients were seen in the clinic weekly
during Ramadan. Weight, height and BMI were recorded, and blood
samples were collected on the ﬁrst and last day of Ramadan. All pa-
tients were provided with a 24 h help line, and asked to record
their home blood glucose regularly and any hypoglycemia epi-
sodes. Evidence of DKA admissions were taken from hospital
records.
During the three months prior to Ramadan, patients in the fast-
ing group were given intensive education and written instructions
provided by diabetic educators, dieticians and physicians on insu-
lin adjustment, home glucose monitoring, dietary adjustments and
activity changes during Ramadan.
2.2. Insulin adjustment
All patients were on multiple daily insulin injections (MDI), and
their written instructions to insulin adjustment were as follows:
 Pre-Iftar dose equal to pre-Ramadan lunch dose of rapid acting
insulin.
 Pre-Sahor dose equal to pre-Ramadan evening dose of rapid act-
ing insulin.
 Pre-Ramadan Basal dose was reduced by 20% and given in the
evening.
Home glucose was monitored pre-Iftar, 3 h post-Iftar, pre-Sahor
and any time during the day when there was a risk of hypoglyce-
mia. If glucose was higher than normal, patients were instructed
to give a corrective dose of one unit of fast acting insulin for each
50 mg above the normal range.
2.3. Biochemical analysis
All patients had blood samples two days prior to, and on the
29th of Ramadan after a minimum of 12 h overnight fast. Blood
glucose, glycosylated hemoglobin (HbA1c) was measured by High
Performance Liquid Chromatography (HPLC) analyzer: Variant II
Company Bio-rad, USA, total cholesterol, triglycerides, low density
lipoprotein (LDL) and high density lipoprotein (HDL).
2.4. Statistical analysis
Analysis of signiﬁcant metabolic changes pre- and post-Rama-
dan was assessed by P value based on analysis by SPSS program
Version 12. Data were expressed in mean ± standard deviation
(SD). Wilcoxon Signed Ranks test was used to ascertain the signif-
icance of the difference between mean values. The P value <0.05
was considered to be the cut off value of signiﬁcance.3. Results
During Ramadan 2007, the average fasting period in Riyadh city
was 12½ h per day, starting at 5 AM (dawn) and ending at 5:30 PM
(sunset).
A total of 20 patients agreed to take part in the study. Twelve
children were in the fasting group, and 8 children in the non-fast-
ing group. Only one child, in the fasting group, withdrew from the
study, due to hypoglycemia experienced on the second day of Ram-
adan, 3 h after the Sahor meal. The fasting group was older, with
mean age of 12.1 years (SD ± 1.1) as compared to non-fasting group
mean age was 10.6 years (SD ± 1.9). Female participants were
slightly higher than male, with 58% in the fasting group and 63%
in the non-fasting group. Across the groups, the duration of diabe-
tes was 2–5 years; the fasting group mean was 2 years, and thenon-fasting group mean was 3 years. The mean hemoglobin A1c,
for the non-fasting group, 6 months before Ramadan was 9.2%
(±1.13) and 6 months after Ramadan was 9.4% (±1.34) and for the
fasting group was 9.13% and 10%, respectively. At the beginning
of Ramadan, the weight of the fasting group was heavier than
the non-fasting group, with a mean of 42.2 kg (±9.6) compared to
the non-fasting group, with a mean of 36.6 kg (±7.4). In both
groups, diabetes control was poor with hemoglobin A1c (HbA1c)
just before Ramadan with a mean of 10.4 (±2.17%) in the fasting
group and 10.6 (±1.4%) in the non-fasting group. The normal refer-
ence in our laboratory, non-diabetic range is 4.4–6.4%.
No patient called the 24 h help line and none had either inter-
current illness or ketosis.
Changes in hemoglobin A1c, weight and lipid proﬁles, before
and at the end of Ramadan between and among the fasting and
non-fasting groups, showed no signiﬁcant statistical difference,
as illustrated in Tables 1 and 2.4. Discussion
Current evidence has proved that with proper education, appro-
priate adjustment of the drug regimen, diet control and daily activ-
ity, it is safe for adult diabetics with Type 1 and Type 2 to fast
during Ramadan [1,4,5,8–12].
Diabetics usually insist on fasting, often without the approval of
their physicians. This insistence may be a reaction against the feel-
ing that due to their disease, they are physiologically different from
other members of the community [13] or from the fact that Ram-
adan fasting is one of ﬁve pillars of Islam and is regarded by all
Muslims as an important facet of the practice of Islam. This
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(EPIDIAR) conducted across 13 countries. This international study
revealed adult diabetic Muslims who chose to fast were 78.7%
and 42.8% in Type 2 and Type 1 diabetes, respectively. Saudi Arabia
was found to be the highest, with 71.6% of Type 1 diabetics choos-
ing to fast [4]. Patel found that 99.1% of Type 2 diabetics opted to
fast at one center in Oman [5].
The management of children with diabetes who choose to fast
during Ramadan is a challenge for pediatrician as the majority of
guidelines and data on safety and metabolic impact of fasting are
based on practice and studies on adult population.
All of our patients completed the full month of fasting except
one, who had hypoglycemia, and none had DKA. Therefore, our
study showed that it is safe for diabetic children under the age of
14 years to fast, provided that a well structured program of educa-
tion for both children and their families is completed prior to Ram-
adan, and that they receive close follow up during the month of
Ramadan.
Data on the effects and safety of Ramadan fasting in healthy and
diabetic adolescents are sparse. An earlier study [6] done in the
same city on children with similar age group reported three
children with biochemical hypoglycemia within the ﬁrst week of
fasting. These episodes contributed to the mis-adjustment of the
insulin dose. More recently, another report [7] looking into the im-
pact of fasting among adolescents with T 1DM treated with insulin
pump versus conventional insulin therapy identiﬁed hypoglycemia
of glucose below 60 mg/dl on an average of 16–29 readings per
month in insulin pump and conventional therapy groups, respec-
tively. However patients in the latter study were older, compared
to ours (15–19 years), and had better HbA1c with an average of
7.8 and 9.1 for insulin pump and conventional therapy, respec-
tively. We suspect that parental supervision, insulin adjustment
and intensive education & follow up are the main reasons for lower
hypoglycemia episodes in our patients. It is also possible that high
food intake and higher HbA1c in our patients provided them with
protection against hypoglycemia.
None of our patients showed signiﬁcant difference in their fast-
ing lipid proﬁle pre- or at the end of Ramadan, compared to an
adult study by Akangi which showed beneﬁcial changes in serum
HDL and LDL in normal adults fasting in Ramadan [14].
Our study had some limitations because of the small number of
patients with Type I diabetes, and it involved only one center in
Riyadh. In spite of these two limitations, the study demonstrates
that children over the age of 8 years old who are well controlled,
educated before Ramadan, have their insulin adjusted and are fol-
lowed closely in the clinic will show no biochemical short termcomplications and be able to successfully complete fasting during
the month of Ramadan.5. Conclusion
It is feasible for children older than 8 years with long-standing T
1DM to safely fast during Ramadan, if the child and family received
proper education and intensive follow up clinic during Ramadan. It
appears that Ramadan fasting has no signiﬁcant effect on diabetes
control or lipid proﬁle; however further studies are recommended
to include a larger sample size with other age groups.Conﬂict of interest statement
None declared.
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